お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
989550

ホルモン避妊薬市場規模調査:ホルモンタイプ別、メソッドタイプ別、エンドユーザー別-2025年までの世界予測-COVID-19の累積的影響

Hormonal Contraceptives Market Research Report by Hormone Type, by Method Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 198 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.25円
ホルモン避妊薬市場規模調査:ホルモンタイプ別、メソッドタイプ別、エンドユーザー別-2025年までの世界予測-COVID-19の累積的影響
出版日: 2021年02月09日
発行: 360iResearch LLP
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のホルモン避妊薬の市場規模は、2020年の142億5867万米ドルから、2025年末までに188億4384万米ドル規模に成長すると予想されています。

COVID-19の累積的影響

COVID-19は、ほぼすべての業界に影響を与えた比類のない世界的な公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されます。私たちの進行中の調査は、調査フレームワークを増幅して、基礎となるCOVID-19の問題と今後の潜在的な道筋を確実に含めるようにしています。調査は消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場の力のダイナミクス、および政府の重要な介入を考慮したCOVID-19に関する洞察を提供しています。更新された調査は、市場へのCOVID-19の影響を考慮して、洞察、分析、推定、および予測を提供します。

360iResearch?競争戦略ウィンドウ

360iResearch?CompetitiveStrategic Windowは、市場、アプリケーション、および地域の観点から競合情勢を分析します。 360iResearch?CompetitiveStrategic Windowは、ベンダーが自社の能力と将来の成長見通しの機会との間の調整または適合を定義するのに役立ちます。予測期間中に、ベンダーが継続的な合併および買収戦略、地域の拡大、研究開発、および新製品のイントロダクション戦略を採用して、さらなる事業の拡大と成長を実行するための最適または有利な適合を定義します。

レポートは、次の指針に関する洞察を提供します。

  • 1.市場浸透:主要なプレーヤーによって提供される市場に関する包括的な情報を提供します
  • 2.市場開発:収益性の高い新興市場に関する詳細な情報を提供し、市場を分析します
  • 3.市場の多様化:新製品の発売、未開発の地域、最近の開発、および投資に関する詳細情報を提供します
  • 4.競争力のある評価とインテリジェンス:主要企業の市場シェア、戦略、製品、製造能力の徹底的な評価を提供します
  • 5.製品開発とイノベーション:将来のテクノロジー、R&D活動、および新製品開発に関する洞察を提供します

レポートは次のような質問に答えます。

  • 1.世界のホルモン避妊薬市場の市場規模と予測はどのくらいですか?
  • 2.予測期間中に世界のホルモン避妊薬市場を形成するCOVID-19の阻害要因と影響は何ですか?
  • 3.世界のホルモン避妊薬市場の予測期間中に投資する製品/セグメント/アプリケーション/領域はどれですか?
  • 4.世界のホルモン避妊薬市場における機会の競争戦略的ウィンドウは何ですか?
  • 5.世界のホルモン避妊薬市場動向技術動向と規制の枠組みは何ですか?
  • 6.世界のホルモン避妊薬市場に参入するのに適していると考えられるモードと戦略的動きは何ですか?

当レポートでは、ホルモン避妊薬市場を調査し、市場概要、市場の成長要因および阻害要因の分析、タイプ別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画を作成する
    • 実行:調査を実施する
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • ホルモンタイプの見通し
  • エンドユーザーの見通し
  • タイプ別の見通し
  • 地域展望
  • 競合他社の見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 ホルモンタイプ別の世界のホルモン避妊薬市場

  • イントロダクション
  • アンドロゲン
  • 抗アンドロゲン
  • エストロゲン
  • ゴナドトロピン
  • プロゲストゲン

第7章 メソッドタイプ別の世界のホルモン避妊薬市場

  • イントロダクション
  • 複合経口避妊薬
  • 埋め込まれた避妊薬
  • 注入された避妊薬
  • 子宮内
  • 経口避妊薬
  • 経皮パッチ
  • 膣リング

第8章 エンドユーザー別の世界のホルモン避妊薬市場

  • イントロダクション
  • 外来手術センター
  • 婦人科センター
  • ホームケア
  • 病院とクリニック

第9章 南北アメリカのホルモン避妊薬市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のホルモン避妊薬市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカのホルモン避妊薬市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第13章 企業のユーザビリティプロファイル

  • AbbVie Inc.
  • Afaxys, Inc
  • Agile Therapeutics
  • Amgen Inc.
  • Ansell Ltd
  • Apothecus Pharmaceutical Corporation
  • Bayer AG
  • BioSante Pharmaceuticals Inc.
  • Boehringer Ingelheim GmbH
  • Church & Dwight, Co., Inc.
  • Cipla Limited
  • Covetrus, Inc.
  • Glenmark Pharmaceuticals
  • HLL Lifecare Limited
  • Johnson & Johnson Services, Inc
  • Lupin Pharmaceuticals, Inc.
  • Mayer Laboratories, Inc
  • Merck & Co. Inc.
  • Mylan N.V
  • Novartis International AG
  • Pfizer, Inc.
  • Piramal Healthcare Limited
  • Reckitt Benckiser Group PLC
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries
  • Vardhman Life Care Pvt. Ltd.
  • Warner Chilcott Company

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

List of Figures

  • FIGURE 1. GLOBAL HORMONAL CONTRACEPTIVES MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL HORMONAL CONTRACEPTIVES MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET: MARKET DYNAMICS
  • FIGURE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 VS 2025 (%)
  • FIGURE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2025
  • FIGURE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 VS 2025 (%)
  • FIGURE 23. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2025
  • FIGURE 25. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, 2020 VS 2025 (USD MILLION)
  • FIGURE 29. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, 2020 VS 2025 (USD MILLION)
  • FIGURE 30. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, 2020 VS 2025 (USD MILLION)
  • FIGURE 31. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, 2020 VS 2025 (USD MILLION)
  • FIGURE 32. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
  • FIGURE 33. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
  • FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2025
  • FIGURE 35. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2020 VS 2025 (USD MILLION)
  • FIGURE 36. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, 2020 VS 2025 (USD MILLION)
  • FIGURE 37. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, 2020 VS 2025 (USD MILLION)
  • FIGURE 38. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, 2020 VS 2025 (USD MILLION)
  • FIGURE 39. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 40. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 41. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 42. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 43. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 44. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 45. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 48. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 50. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 58. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 59. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 60. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 62. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 63. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 64. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 65. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 66. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 67. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 68. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 69. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 70. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 71. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 72. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 73. GLOBAL HORMONAL CONTRACEPTIVES MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 74. GLOBAL HORMONAL CONTRACEPTIVES MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 75. GLOBAL HORMONAL CONTRACEPTIVES MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HORMONAL CONTRACEPTIVES MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANDROGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ANTIANDROGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ESTROGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GONADOTROPINS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY PROGESTOGENS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY IMPLANTED CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INJECTED CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY INTRAUTERINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY ORAL CONTRACEPTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY TRANSDERMAL PATCH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY VAGINAL RING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY GYNECOLOGY CENTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOMECARE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HOSPITALS & CLINICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. ARGENTINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. BRAZIL HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CANADA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. MEXICO HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. AUSTRALIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. CHINA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. INDIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. INDONESIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. JAPAN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. MALAYSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. PHILIPPINES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. SOUTH KOREA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. THAILAND HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. FRANCE HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. GERMANY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. ITALY HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. NETHERLANDS HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. QATAR HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. RUSSIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. SAUDI ARABIA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. SOUTH AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. SPAIN HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. UNITED ARAB EMIRATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. UNITED KINGDOM HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. GLOBAL HORMONAL CONTRACEPTIVES MARKET: SCORES
  • TABLE 111. GLOBAL HORMONAL CONTRACEPTIVES MARKET: BUSINESS STRATEGY
  • TABLE 112. GLOBAL HORMONAL CONTRACEPTIVES MARKET: PRODUCT SATISFACTION
  • TABLE 113. GLOBAL HORMONAL CONTRACEPTIVES MARKET: RANKING
  • TABLE 114. GLOBAL HORMONAL CONTRACEPTIVES MARKET: MERGER & ACQUISITION
  • TABLE 115. GLOBAL HORMONAL CONTRACEPTIVES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 116. GLOBAL HORMONAL CONTRACEPTIVES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 117. GLOBAL HORMONAL CONTRACEPTIVES MARKET: INVESTMENT & FUNDING
  • TABLE 118. GLOBAL HORMONAL CONTRACEPTIVES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 119. GLOBAL HORMONAL CONTRACEPTIVES MARKET: LICENSE & PRICING
目次
Product Code: MRR-31E067C

Title:
Hormonal Contraceptives Market Research Report by Hormone Type (Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens), by Method Type (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, and Oral Contraceptives), by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

  • 1. The Global Hormonal Contraceptives Market is expected to grow from USD 14,258.67 Million in 2020 to USD 18,843.84 Million by the end of 2025.
  • 2. The Global Hormonal Contraceptives Market is expected to grow from EUR 12,502.27 Million in 2020 to EUR 16,522.63 Million by the end of 2025.
  • 3. The Global Hormonal Contraceptives Market is expected to grow from GBP 11,114.54 Million in 2020 to GBP 14,688.66 Million by the end of 2025.
  • 4. The Global Hormonal Contraceptives Market is expected to grow from JPY 1,521,761.40 Million in 2020 to JPY 2,011,115.23 Million by the end of 2025.
  • 5. The Global Hormonal Contraceptives Market is expected to grow from AUD 20,705.48 Million in 2020 to AUD 27,363.76 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Hormonal Contraceptives to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Hormone Type, the Hormonal Contraceptives Market studied across Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens.
  • Based on Method Type, the Hormonal Contraceptives Market studied across Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Oral Contraceptives, Transdermal Patch, and Vaginal Ring.
  • Based on End-user, the Hormonal Contraceptives Market studied across Ambulatory Surgical Centers, Gynecology Centers, Homecare, and Hospitals & Clinics.
  • Based on Geography, the Hormonal Contraceptives Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Hormonal Contraceptives Market including AbbVie Inc., Afaxys, Inc, Agile Therapeutics, Amgen Inc., Ansell Ltd, Apothecus Pharmaceutical Corporation, Bayer AG, BioSante Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Church & Dwight, Co., Inc., Cipla Limited, Covetrus, Inc., Glenmark Pharmaceuticals, HLL Lifecare Limited, Johnson & Johnson Services, Inc, Lupin Pharmaceuticals, Inc., Mayer Laboratories, Inc, Merck & Co. Inc., Mylan N.V, Novartis International AG, Pfizer, Inc., Piramal Healthcare Limited, Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries, Vardhman Life Care Pvt. Ltd., and Warner Chilcott Company.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Hormonal Contraceptives Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Hormonal Contraceptives Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hormonal Contraceptives Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hormonal Contraceptives Market?
  • 4. What is the competitive strategic window for opportunities in the Global Hormonal Contraceptives Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Hormonal Contraceptives Market?
  • 6. What are the modes and strategic moves considered suitable for entering the Global Hormonal Contraceptives Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Hormone Type Outlook
  • 3.4. End-user Outlook
  • 3.5. Method Type Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness about the benefits and use of contraceptives
      • 5.1.1.2. Government initiatives to promote the use of contraceptives
      • 5.1.1.3. Need for oral contraceptives as a preferred method to avoid unplanned pregnancy
    • 5.1.2. Restraints
      • 5.1.2.1. Growing use of biologics instead of traditional chemical drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for a healthy life in emerging economies
      • 5.1.3.2. Technological advancements in contraceptive methods
    • 5.1.4. Challenges
      • 5.1.4.1. Limited social acceptance
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Hormonal Contraceptives Market, By Hormone Type

  • 6.1. Introduction
  • 6.2. Androgens
  • 6.3. Antiandrogens
  • 6.4. Estrogens
  • 6.5. Gonadotropins
  • 6.6. Progestogens

7. Global Hormonal Contraceptives Market, By Method Type

  • 7.1. Introduction
  • 7.2. Combined Oral Contraceptives
  • 7.3. Implanted Contraceptives
  • 7.4. Injected Contraceptives
  • 7.5. Intrauterine
  • 7.6. Oral Contraceptives
  • 7.7. Transdermal Patch
  • 7.8. Vaginal Ring

8. Global Hormonal Contraceptives Market, By End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Gynecology Centers
  • 8.4. Homecare
  • 8.5. Hospitals & Clinics

9. Americas Hormonal Contraceptives Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hormonal Contraceptives Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. South Korea
  • 10.10. Thailand

11. Europe, Middle East & Africa Hormonal Contraceptives Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis
  • 12.4. Competitor SWOT Analysis
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AbbVie Inc.
  • 13.2. Afaxys, Inc
  • 13.3. Agile Therapeutics
  • 13.4. Amgen Inc.
  • 13.5. Ansell Ltd
  • 13.6. Apothecus Pharmaceutical Corporation
  • 13.7. Bayer AG
  • 13.8. BioSante Pharmaceuticals Inc.
  • 13.9. Boehringer Ingelheim GmbH
  • 13.10. Church & Dwight, Co., Inc.
  • 13.11. Cipla Limited
  • 13.12. Covetrus, Inc.
  • 13.13. Glenmark Pharmaceuticals
  • 13.14. HLL Lifecare Limited
  • 13.15. Johnson & Johnson Services, Inc
  • 13.16. Lupin Pharmaceuticals, Inc.
  • 13.17. Mayer Laboratories, Inc
  • 13.18. Merck & Co. Inc.
  • 13.19. Mylan N.V
  • 13.20. Novartis International AG
  • 13.21. Pfizer, Inc.
  • 13.22. Piramal Healthcare Limited
  • 13.23. Reckitt Benckiser Group PLC
  • 13.24. Sun Pharmaceutical Industries Ltd.
  • 13.25. Teva Pharmaceutical Industries
  • 13.26. Vardhman Life Care Pvt. Ltd.
  • 13.27. Warner Chilcott Company

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.